Lobenzarit sodium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular structure C14H8CLNO4.2NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 7Z9SP74BXF chemically known as benzoic acid, 2-((2-carboxyphenyl)amino)-4-chloro-, disodium salt, but more commonly known as lobenzarit sodium, which bears US NIH Compound Identifier 47462. European Medicines Agency schedules Lobenzarit sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02963MIG. Most nations, for tariff and trade purposes, schedule lobenzarit sodium under HS 29224995 and SITC 51465. As of Q4 2014, LOBENZARIT SODIUM remains US FDA's Preferred Term for this commodity. Lobenzarit sodium bears US NLM identifiers UMLS ID C0126105 and NCI Concept Code C72817. SMILES: C1CCC(C(C1)C(=O)[O-])NC2CC(CCC2C(=O)[O-])CL.[NA+].[NA+].